BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
BioXcel Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 17.43M | 31.01M | 29.85M | 40.39M | 56.27M | 74.14M | 65.22M | 89.96M | 127.55M | 165.52M | 193.72M | 232.31M | 233.45M | 200.44M | 232.97M | 252.91M | 273.06M | 194.01M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 87K | 87K | 87K | 87K | 87K | 87K | 87K | 87K | 925K | 925K | 925K | 925K | 965K | 3.93M | 1.75M | 1.63M | 633K |
Receivables | 17K | n/a | 131K | 3K | 812K | 378K | 71K | 735K | 431K | 283K | 248K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 506K | 642K | 679K | 1.52M | 2.68M | 2.44M | 1.99M | 2.02M | 1.93M | 1.95M | 1.99M | 1.41M | 1.4M | 682K | n/a | n/a | n/a | n/a |
Other Current Assets | 7.29M | 1.39M | 1.44M | 1.4M | 1.64M | 1.86M | 2.08M | 2.17M | 4.64M | 5.01M | 3.84M | 2.43M | 1.69M | 1.48M | 956K | n/a | 3.6M | 2.77M |
Total Current Assets | 25.24M | 37.78M | 37.39M | 47.79M | 64.18M | 80.92M | 72.14M | 98.74M | 138.24M | 177.27M | 202.87M | 241.66M | 244.92M | 207.56M | 232.97M | 256.93M | 276.66M | 196.78M |
Property-Plant & Equipment | 546K | 702K | 857K | 1.01M | 1.17M | 1.32M | 1.47M | 1.62M | 1.77M | 1.91M | 2.06M | 2.23M | 2.39M | 2.52M | 2.54M | 2.65M | 2.82M | 2.97M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 546K | 789K | 944K | 1.1M | 1.25M | 1.41M | 1.56M | 1.71M | 1.86M | 2.83M | 2.98M | 3.16M | 3.31M | 3.48M | 6.47M | 4.4M | 4.45M | 3.61M |
Total Assets | 25.79M | 38.57M | 38.34M | 48.89M | 65.44M | 82.32M | 73.7M | 100.45M | 140.1M | 180.1M | 205.85M | 244.82M | 248.24M | 211.04M | 239.44M | 261.33M | 281.11M | 200.39M |
Account Payables | 16.69M | 15.45M | 15.99M | 14.89M | 13.26M | 17.22M | 13.65M | 10.67M | 11.2M | 7.74M | 10.23M | 5.87M | 6.02M | 5.07M | 4.68M | 3.44M | 2.5M | 5.31M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 85K | 116K | -339K | 23.09M | n/a | n/a | n/a | n/a | n/a | -293K | 199K | -281K | -275K |
Short-Term Debt | 11.47M | 5.61M | n/a | n/a | n/a | 353K | 346K | 339K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 5.06M | 173K | 142K | 10.19M | 2.44M | 12.48M | 12.53M | 602K | 4.16M | 2.81M | 6.46M | 4.83M | 10.07M | 8.41M | 7.43M | 154K | 7.22M | 4.76M |
Total Current Liabilities | 33.38M | 25.55M | 22.23M | 25.56M | 27.29M | 31.48M | 27.27M | 39.41M | 34.74M | 28.76M | 32.9M | 23.38M | 20M | 16M | 16.67M | 14.6M | 12.44M | 12.32M |
Long-Term Debt | 97.47M | 99.92M | 102.51M | 104.44M | 103.01M | 101.63M | 100.6M | 99.09M | 97.46M | 95.77M | 93.84M | 91.69M | 62.02M | 1.03M | 1.1M | 1.18M | 1.25M | 1.33M |
Other Long-Term Liabilities | 2.61M | 3.27M | 6.63M | 4.37M | 9.19M | 21.22M | 1.91M | 2.03M | 1.41M | 1.87M | 1.56M | 1.89M | 1M | -1.03M | -1.1M | -1.18M | -1.25M | -1.33M |
Total Long-Term Liabilities | 100.08M | 103.19M | 109.21M | 108.97M | 112.45M | 123.2M | 102.94M | 101.65M | 99.49M | 98.34M | 96.18M | 94.45M | 63.98M | 1.03M | 1.1M | 1.18M | 1.25M | 1.33M |
Total Liabilities | 133.46M | 128.74M | 131.44M | 134.53M | 139.74M | 154.69M | 130.21M | 141.06M | 134.23M | 127.1M | 129.08M | 117.83M | 83.97M | 17.02M | 17.77M | 15.78M | 13.7M | 13.65M |
Total Debt | 108.69M | 105.91M | 102.95M | 104.97M | 103.26M | 102.34M | 101.38M | 99.62M | 97.8M | 96.09M | 94.16M | 92.88M | 62.33M | 1.33M | 1.4M | 1.47M | 1.25M | 1.33M |
Common Stock | 60K | 59K | 49K | 42K | 40K | 34K | 30K | 29K | 29K | 29K | 28K | 28K | 28K | 28K | 28K | 28K | 28K | 25K |
Retained Earnings | -676.64M | -657.45M | -650.2M | -639.34M | -625.69M | -617.39M | -590.6M | -568.34M | -517.86M | -464.34M | -411.55M | -356.74M | -314.93M | -277.26M | -245.79M | -219.66M | -192.85M | -165.23M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | n/a | n/a | 0.00 | -0.00 | n/a |
Shareholders Equity | -107.67M | -90.17M | -93.1M | -85.63M | -74.3M | -72.36M | -56.51M | -40.61M | 5.86M | 53.01M | 76.78M | 126.99M | 164.26M | 194.02M | 221.67M | 245.56M | 267.41M | 186.74M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |